Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Science Progress|October 13, 2020
Optimization and analysis of a grounded type dynamic vibration absorber with lever componentYongjun Shen, Zikang Xing, Shaopu Yang, et al.
The Review of Scientific Instruments|July 10, 2021
A 6.78-MHz distance-insensitive wireless power transfer system with a dual-coupled L-type matching networkGao Han, Yanming Liu, Qian Li, et al.
Pharmaceutics|July 27, 2024
IDO1 Inhibitor RY103 Suppresses Trp-GCN2-Mediated Angiogenesis and Counters Immunosuppression in GlioblastomaZikang Xing, Xuewen Li, Zhen Ning Tony He, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 9, 2021
What is the prospect of indoleamine 2,3-dioxygenase 1 inhibition in cancer? Extrapolation from the pastYu Yao, Heng Liang, Xin Fang, et al.
Signal Transduction and Targeted Therapy|April 17, 2020
Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn-AhR-AQP4 signaling pathwayLisha Du, Zikang Xing, Bangbao Tao, et al.
Pharmacological Research|February 20, 2022
IDO1 can impair NK cells function against non-small cell lung cancer by downregulation of NKG2D Ligand via ADAM10Xin Fang, Leilei Guo, Zikang Xing, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 20, 2019
H2S suppresses indoleamine 2, 3-dioxygenase 1 and exhibits immunotherapeutic efficacy in murine hepatocellular carcinomaDan Yang, Tianqi Li, Yinlong Li, et al.
Cancer Letters|September 14, 2021
IDO1/TDO dual inhibitor RY103 targets Kyn-AhR pathway and exhibits preclinical efficacy on pancreatic cancerHeng Liang, Tianqi Li, Xin Fang, et al.
Pageof 1